Kaj je WAS EVALUATED v Slovenščini - Slovenski prevod

• so ocenili
• so ocenjevali
• je bila ocenjena
• so ovrednotili
• je bil ovrednoten
• so vrednotili
• ovrednotena
• so preučevali
• je bila ovrednotena
• je bil ocenjen
• je bilo ocenjeno
• je ocenjevala
• sta bili ovrednoteni
• sta bili ocenjeni

Primeri uporabe Was evaluated v Angleški in njihovi prevodi v Slovenski

Pain was evaluated by a VAS scale.
Bolečino smo ocenjevali z VAS lestvico.

The methodological quality was evaluated.
Ocenjevala se je metodološka kvaliteta.

Efficacy was evaluated in 2,928 patients.
Učinkovitost so preučevali pri 2928 bolnicah.

Every phase of our progress was evaluated.
Vsak korak, vsaka faza dela je bila ovrednotena.

Efficacy was evaluated in 2,928 patients.
Učinkovitost so proučevali pri 2928 bolnicah.

Maintenance of clinical remission was evaluated in CHARM.
Vzdrževanje klinične remisije je ocenjevala študija CHARM.

The whole project was evaluated by the budget in$ 20 billion.
Celoten projekt je bil ocenjen s proračunom v 20 milijard dolarjev.

The percieved value was REAL at the time it was evaluated.
Bile so realne za čas, ko se je ocenjevalo.

FN-2187 reported to my division, was evaluated and sent to reconditioning.
FN-2187 se je javil, bil ocenjen in poslan na obnovo.

The effect of age was evaluated in a population pharmacokinetic analysis on plasma migalastat clearance in the ERT-naïve study population.
Učinek starosti so vrednotili s populacijsko farmakokinetično analizo plazemskega očistka migalastata pri populaciji, ki še ni prejemala ERT.

Maintenance of clinical remission was evaluated in CD Study I(CHARM).
Vzdrževanje klinične remisije je ocenjevala študija pri Crohnovi bolezni III(CHARM).

Each application and tender was evaluated according to clear predefined criteria that were published at the beginning of the tendering procedure.
Vsaka prijava in ponudba je bila ocenjena po jasnih in vnaprej določenih merilih, ki so bili objavljeni ob začetku razpisnega postopka.

In both studies the primary efficacy endpoint was evaluated at 52 weeks.
V obeh študijah so primarni opazovani dogodek učinkovitosti ocenili po 52 tednih.

Treatment efficacy was evaluated three months after the beginning of treatment.
Učinkovitost zdravljenja se oceni po treh dneh od začetka postopka.

The immunogenicity of IXIARO administered in a rapid vaccination schedule was evaluated in a randomized, observer-blind, phase 3 study.
Imunogenost cepiva IXIARO, odmerjenega med hitrim urnikom cepljenja, je bila ocenjena v randomizirani, za ocenjevalca slepi študiji 3. faze.

The pharmacokinetics of eculizumab was evaluated in Study M07-005 including 7 PNH paediatric patients(aged from 11 to less than 18 years).
Farmakokinetika ekulizumaba je bila ocenjena v študiji M07-005, ki je vključevala 7 pediatričnih bolnikov s PNH(starih od 11 do manj kot 18 let).

Potential in vivo genotoxicity of florbetapir was evaluated in a rat micronucleus study.
Potencialno genotoksičnost florbetapirja in vivo so vrednotili v študiji mikronukleusov pri podganah.

The pharmacokinetics of opicapone was evaluated in healthy subjects and moderate chronic hepatic impaired patients after administration of a single-dose of 50 mg.
Farmakokinetiko opikapona so ovrednotili pri zdravih osebah in pri bolnikih z zmerno kronično okvaro jeter po dajanju enega odmerka 50 mg.

Adherence to the Mediterranean diet was evaluated using the 11-component MedDietScore.
Upoštevanje mediteranske prehrane je bilo ocenjeno z uporabo 11-komponentne MedDietScore.

Virologic response rate was evaluated in both treatment arms and virologic response was defined as achieving an undetectable viral load(< 50 HIV-1 RNA copies/ml).
Stopnja virološkega odziva je bila ocenjena v obeh krakih zdravljenja, virološki odziv je bil opredeljen kot dosežena nezaznavna virusna obremenitev(< 50 RNA HIV-1 kopij/ml).

In a supplemental analysis, the efficacy of Silgard was evaluated against HPV 16/ 18-related CIN 3 and AIS.
Z dodatno analizo je bila ovrednotena še učinkovitost cepiva Silgard proti CIN 3 in AIS zaradi HPV 16/ 18.

The efficiency of the Programme was evaluated through questions about overall satisfaction with the implementation, the efficiency of the activities, the adequacy of funding and its leveraging effect.
Učinkovitost programa je bila ocenjena z vprašanji o splošnem zadovoljstvu z izvajanjem, učinkovitosti dejavnosti, zadostnosti finančnih sredstev in njihovem učinku finančnega vzvodja.

The safety profile of aprepitant was evaluated in approximately 6,500 individuals.
Varnostni profil aprepitanta je bil ovrednoten pri približno 6.500 osebah.

The efficacy and safety of degarelix was evaluated in an open-label, multi-centre, randomised, active comparator controlled, parallel-group study.
Učinkovitost in varnost degareliksa so ovrednotili v odprti, multicentrični, randomizirani študiji s paralelnimi skupinami, kontrolirani z aktivnim primerjalnim zdravilom.

The impact of Directive 2010/73/EU was evaluated three years after its entry into application.
Učinek Direktive 2010/73/EU je bil ocenjen tri leta po začetku veljavnosti.

The effect of gender on lumacaftor pharmacokinetics was evaluated using a population pharmacokinetics analysis of data from clinical studies of lumacaftor given in combination with ivacaftor.
Vpliv spola na farmakokinetiko lumakaftorja so ovrednotili s populacijsko farmakokinetično analizo podatkov iz kliničnih študij lumakaftorja, dajanega v kombinaciji z ivafaktorjem.

Twelve-month persistent infection was evaluated as additional efficacy endpoint.
Kot dodaten opazovani dogodek učinkovitosti je bila vrednotena dvanajstmesečna persistentna okužba.

Adherence to the Mediterranean diet was evaluated using the 11-components MedDietScore(theoretical range 0-55).
Upoštevanje mediteranske prehrane je bilo ocenjeno z uporabo 11-komponentne MedDietScore.

Results of the confirmatory Phase III study The efficacy and safety of degarelix was evaluated in an open-label, multi-centre, randomised, active comparator controlled, parallel-group study.
Rezultati potrditvene študije faze III Učinkovitost in varnost degareliksa so ovrednotili v odprti, multicentrični, randomizirani študiji s paralelnimi skupinami, kontrolirani z aktivnim primerjalnim zdravilom.

The influence of gender on eltrombopag pharmacokinetics was evaluated using population pharmacokinetics analysis in 635 patients with HCV(260 females).
Vpliv spola na farmakokinetiko eltrombopaga je bil ovrednoten z analizo populacijske farmakokinetike pri 635 bolnikih s HCV(260 oseb ženskega spola).